Start
Completion

Effect of Subanesthetic Dose of Ketamine Combined With Propofol on Cognitive Function in Depressive Patients Undergoing Electroconvulsive Therapy

Unknown statusRegisteredCTG

The purpose of this study is to determine whether subanesthetic dose of ketamine combined with propofol is superior to propofol anesthesia alone in improving cognitive function in depressive patients undergoing ECT

Details

This randomised, double-blind, parallel-group trial (n=132) compares IV ketamine 0.3 mg/kg plus propofol 1.5 mg/kg versus propofol 1.5 mg/kg plus saline in patients receiving ECT to assess cognitive outcomes.

Rationale: ECT is effective for severe depression but often causes cognitive dysfunction; preclinical and early clinical data suggest subanesthetic ketamine may protect or improve cognition when combined with anaesthesia.

Primary outcome: cognitive function rated by the Mini-Mental State Examination (MMSE); procedures include IV infusions prior to ECT with standard succinylcholine muscle relaxation and bitemporal electrode placement.

Topics:Major Depressive Disorder (MDD)

Registry

Registry linkNCT02305394